Monterona, Richard C.
HRN: 21-64-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/21/2022
07/28/2022
IV
500 Mg
Q8
Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes